General Information
BounceWatch is an independent company data service, not affiliated with BioPheresis. To contact BioPheresis, visit biopheresis.de.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does BioPheresis compare?
A PDF of BioPheresis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting BioPheresis soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is BioPheresis on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About BioPheresis
Business keywords: Cancer treatment, Blood purification, Immune-inhibitors, BioPheresis Technologies, Innovative technology, Patent-protected system, Medical technology, Healthcare innovation, Research and development, Biomedical engineering, Oncology, Immunotherapy, Medical devices, Clinical trials
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $8.00M | 2 |
firstVentury Equity, SLS Venture
|
13 May 2005 |
BioPheresis Alternatives & Competitors
View All AlternativesCreating affordable anticancer immunotherapies with natural killer (NK) cells
合源生物科技(天津)有限公司创立于2018年6月,是一家专注于免疫细胞治疗等创新型药物研发和商业化的生物...
We make cancer immunotherapies more powerful.
FAQ About BioPheresis
Source: BounceWatch company record for BioPheresis, https://bouncewatch.com/company/biopheresis, updated 24 December 2024. When citing, please name BounceWatch and link this page.